
Dr Reddys Laboratories Ltd
Showing
DRREDDY
Past performance
About Dr Reddys Laboratories Ltd Dr Reddy's Laboratories Ltd (DRL) is a prominent global pharmaceutical company founded in 1984 and headquartered in Hyderabad, India. It focuses on providing affordable and innovative medicines through its three main business segments: Pharmaceutical Services & Active Ingredients, Global Generics, and Proprietary Products. The company's diverse product portfolio includes Active Pharmaceutical Ingredients (APIs), generics, biosimilars, and differentiated formulations, with major therapeutic areas in gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology.
Dr Reddy's operates in key international markets, including the USA, India, Russia, CIS countries, and Europe. Over the years, the company has made strategic acquisitions, expanded its R&D capabilities, and entered into numerous collaborations and licensing agreements to enhance its product offerings. The company has also been actively involved in filing Abbreviated New Drug Applications (ANDAs) and New Drug Applications (NDAs) with the USFDA, reflecting its commitment to expanding its generic drug portfolio. Despite challenges like cybersecurity incidents and regulatory warnings, Dr Reddy's continues to strengthen its market presence and focus on innovation.
Performance overview
